SCHIZOPHRENIA BULLETIN

Scope & Guideline

Illuminating the path to improved mental health.

Introduction

Delve into the academic richness of SCHIZOPHRENIA BULLETIN with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0586-7614
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1973 to 2024
AbbreviationSCHIZOPHRENIA BULL / Schizophr. Bull.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The 'Schizophrenia Bulletin' focuses on advancing the understanding of schizophrenia and related disorders through a multidisciplinary approach. The journal aims to disseminate high-quality research that spans various aspects of schizophrenia, including neurobiological, psychological, and social dimensions.
  1. Neurobiological Mechanisms:
    Research exploring the underlying neurobiological mechanisms of schizophrenia, including genetics, neuroimaging, and molecular biology, to better understand the pathophysiology of the disorder.
  2. Psychological and Cognitive Aspects:
    Studies examining cognitive deficits, emotional regulation, and psychosocial factors that contribute to the experience of schizophrenia, emphasizing the interplay between mental processes and symptoms.
  3. Treatment and Intervention Strategies:
    Investigations into pharmacological and non-pharmacological interventions, including cognitive remediation, psychosocial therapies, and innovative treatment approaches such as digital health interventions.
  4. Epidemiological and Public Health Perspectives:
    Research addressing epidemiology, risk factors, and health disparities related to schizophrenia, focusing on societal impacts and the effectiveness of public health strategies.
  5. Transdiagnostic Approaches:
    Explorations of concepts that span various psychiatric disorders, including the study of psychosis risk and shared mechanisms with other mental health conditions.
The 'Schizophrenia Bulletin' has shown a dynamic shift in focus towards emerging themes that resonate with current clinical and societal needs in the field of schizophrenia research.
  1. Digital Health Interventions:
    A growing number of studies explore the efficacy of digital health technologies, such as teletherapy and mobile health applications, highlighting their potential to improve access to care and patient outcomes.
  2. Transdiagnostic Research:
    An increase in research that examines psychosis across various diagnostic categories, emphasizing shared mechanisms and risk factors, reflecting a move towards understanding mental health in a more integrated manner.
  3. Cognitive Remediation and Functionality:
    There is a notable rise in studies investigating cognitive remediation strategies aimed at improving functional outcomes in individuals with schizophrenia, indicating a shift towards enhancing quality of life.
  4. Social and Environmental Factors:
    Emerging research emphasizes the role of social determinants, such as socioeconomic status and childhood adversity, in the onset and progression of schizophrenia, underscoring the need for a holistic understanding of the disorder.
  5. Machine Learning and AI in Psychiatry:
    The application of machine learning and artificial intelligence to predict treatment responses, identify biomarkers, and enhance diagnostic accuracy is on the rise, indicating a trend towards incorporating advanced technology in psychiatric research.

Declining or Waning

While the journal continues to cover a broad range of topics, certain areas of research appear to be declining in prominence based on recent publications.
  1. Historical Perspectives on Antipsychotic Medications:
    Although historical analyses of antipsychotic medications have been foundational, recent publications indicate a shift towards contemporary research focusing on innovative interventions and current treatment paradigms.
  2. Single-Disease Focus:
    There seems to be a waning emphasis on studies that exclusively examine schizophrenia without considering comorbid conditions or broader psychiatric contexts, reflecting a trend towards more integrated approaches.
  3. Basic Science Studies:
    The volume of purely basic science studies, such as animal models without translational implications, appears to be decreasing, as the journal increasingly prioritizes research with direct clinical relevance.

Similar Journals

Spanish Journal of Psychiatry and Mental Health

Empowering minds: Where psychiatry meets groundbreaking insights.
Publisher: ELSEVIER ESPANA SLUISSN: 2950-2861Frequency: 4 issues/year

Welcome to the Spanish Journal of Psychiatry and Mental Health, a leading platform for innovative research and discourse in the fields of psychiatry and mental health. Published by ELSEVIER ESPANA SLU, this peer-reviewed journal serves as a critical resource for clinicians, researchers, and students dedicated to advancing understanding and treatment of mental health disorders. With a commendable ranking of #54 out of 567 in the Psychiatry and Mental Health category according to Scopus, it proudly positions itself in the 90th percentile, reinforcing its significance within the academic community. As an open-access journal, it aims to disseminate high-quality research to a global audience, promoting collaboration and knowledge sharing among mental health professionals. The journal's dynamic publication schedule, covering Converged Years from 2023 to 2024, ensures that it remains at the forefront of mental health scholarship. We invite you to explore the latest findings, engage with thought-provoking articles, and contribute to the ongoing dialogue in this vital discipline.

JAMA Psychiatry

Bridging Research and Real-World Impact in Psychiatry
Publisher: AMER MEDICAL ASSOCISSN: 2168-622XFrequency: 12 issues/year

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.

American Journal of Alzheimers Disease and Other Dementias

Unlocking insights into Alzheimer's and dementia.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

Schizophrenia Research-Cognition

Unlocking the cognitive mysteries of schizophrenia.
Publisher: ELSEVIERISSN: 2215-0013Frequency: 4 issues/year

Schizophrenia Research-Cognition is an esteemed journal dedicated to advancing the understanding of cognitive aspects of schizophrenia and related mental health disorders. Published by Elsevier, this Open Access journal has been a pivotal platform since its inception in 2014, facilitating the dissemination of high-quality research findings to a global audience. With a notable impact factor and categorized in the Q2 quartile for both Cognitive Neuroscience and Psychiatry and Mental Health, it ranks among the top journals in these fields, currently positioned at #171 out of 567 in Psychiatry and at #40 out of 115 in Cognitive Neuroscience according to Scopus metrics. Located in the United States, and published under the auspices of Elsevier, the journal aims to provide an insightful forum for researchers, clinicians, and students interested in the cognitive underpinnings of schizophrenia, promoting innovative research that bridges the gap between cognitive neuroscience and clinical application. Schizophrenia Research-Cognition's commitment to open access ensures wide-reaching impact and engagement from the research community and beyond.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Advancing the Frontiers of Psychiatry and Neuroscience
Publisher: SPRINGER HEIDELBERGISSN: 0940-1334Frequency: 6 issues/year

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

PSYCHOLOGICAL MEDICINE

Advancing the frontiers of mental health research.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0033-2917Frequency: 16 issues/year

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

NPJ Schizophrenia

Advancing psychiatric research for a deeper understanding of schizophrenia.
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

NPJ Schizophrenia is a premier open-access journal published by NATURE PORTFOLIO, dedicated to advancing the field of psychiatric research with a focus on schizophrenia and related mental health disorders. Since its inception in 2015, the journal has established itself as a leading platform for disseminating high-quality research, reflected in its impressive 2023 impact metrics: Q1 rankings in Biological Psychiatry, Clinical Psychology, and Psychiatry and Mental Health. With its global reach and rigorous peer-review process, NPJ Schizophrenia fosters collaboration among researchers, clinicians, and policymakers, enhancing understanding and treatment of this complex condition. The journal is available to a worldwide audience, promoting accessibility to vital information that shapes future research and clinical practices. Engaging with NPJ Schizophrenia means contributing to a pivotal conversation in the mental health field, making it an essential resource for those dedicated to improving patient outcomes.

Psychiatria Polska

Exploring the depths of psychiatry and mental wellness.
Publisher: WYDAWNICZY POLSKIEGO TOWARZYSTWAISSN: 0033-2674Frequency: 6 issues/year

Psychiatria Polska is a distinguished journal published by WYDAWNICZY POLSKIEGO TOWARZYSTWA, focused on advancing the field of psychiatry and mental health. Established in 1967, this journal has become a vital resource for researchers, clinicians, and students, contributing to the understanding of psychiatric disorders and their treatments. With an ISSN of 0033-2674, it features a diverse range of studies, case reports, and reviews, making it an essential platform for sharing innovative findings within the psychiatric community. Although currently categorized in the Q3 quartile for both Medicine (miscellaneous) and Psychiatry and Mental Health in 2023, its increasing impact is evidenced by its Scopus ranking of #345 out of 567 in its category, placing it in the 39th percentile. Located in Cracow, Poland, Psychiatria Polska continues to foster international collaboration and knowledge exchange, despite being non-open access, ensuring that its high-quality content reaches a wide audience. This journal is dedicated to enhancing the dialogue on mental health, making it an indispensable resource for those committed to improving psychiatric practice and research.

BJPsych Open

Exploring the forefront of psychiatry and mental well-being.
Publisher: CAMBRIDGE UNIV PRESSISSN: 2056-4724Frequency: 6 issues/year

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Exploring the vital link between aging and mental well-being.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.